Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses-Reference-Cited by-同舟云学术

Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses

Published:2017-03 Issue: Volume:249 Page:74-83
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

McKay Paul F.^ORCID,Mann Jamie F.S.,Pattani Aditya,Kett Vicky^ORCID,Aldon Yoann^ORCID,King Deborah,Malcolm R. Karl,Shattock Robin J.

Funder

Bill and Melinda Gates Foundation

Wellcome Trust

Dormeur Investment Service Ltd

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference33 articles.

1. Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen;McKay;PLoS One,2014

2. TLR4 and TLR7/8 adjuvant combinations generate different vaccine antigen-specific immune outcomes in Minipigs when administered via the ID or IN routes;McKay;PLoS One,2016

3. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis;Habibi;Mol. Immunol.,2015

4. Generation of female genital tract antibody responses by local or central (common) mucosal immunization;Wu;Infect. Immun.,2000

5. Induction of mucosal immune responses in the human genital tract;Mestecky;FEMS Immunol. Med. Microbiol.,2000

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vagina, a promising route for drug delivery;Journal of Drug Delivery Science and Technology;2024-01

2. New approaches to vaccines for infectious diseases;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

3. Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity;European Journal of Pharmaceutics and Biopharmaceutics;2023-10

4. Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease;Journal of Virology;2023-09-28

5. Fused deposition modeling three-dimensional printing of flexible polyurethane intravaginal rings with controlled tunable release profiles for multiple active drugs;Drug Delivery and Translational Research;2022-02-24